Portfolio company spotlight

Sparing Vision Acquires GAMUT Therapeutics and Xealth Leader Nominated for CEO of the Year

May 2021

Xealth, Sparing Vision, and Code Biotherapeutics were among the UPMC Enterprises’ portfolio companies in the …

Read More

Infectious Disease Connect is on a Growth Track, and More Portfolio Company News

APRIL 2021

ID Connect, Prodigo Solutions, RxAnte, and more UPMC Enterprises’ portfolio companies were in the news …

Read More

Cavulus announces appointment of UPMC CIO Ed McCallister to board of directors and other portfolio company news

MARCH 2021

Cavulus announces appointment of UPMC CIO Ed McCallister to board of directors

In 2014, McCallister was …

Read More

Alung experiencing increased demand for Hemolung Respiratory Assist System, Bluesphere Bio raises $45M, and other portfolio news

FEBRUARY 2021

Hemolung® RAS used to treat more than 75 COVID-19 patients

ALung Technologies, Inc. announced that it …

Read More

Cerevance achieves primary endpoint in phase Ib schizophrenia cognition study, RxAnte clients outperform industry peers, and other portfolio news

NOVEMBER 2020

Rapid method finds potent COVID-19 monoclonal antibody among a trillion possibilities

Pittsburgh scientists have discovered the …

Read More

Arkos Health partners with Braidio, BlueSphere Bio aims to cure cancer, and other portfolio news

OCTOBER 2020

This AI startup raised $15 million to help patients transcribe doctor appointments

Wouldn’t it be great …

Read More

Abound Bio licenses drug that could treat and prevent COVID-19, BlueSphere Bio names VP of Product Development, and more portfolio news

SEPTEMBER 2020

Yufan Biotechnologies and Abound Bio Sign Multi-Year Agreement to Develop Next Generation CAR T-cell Therapies …

Read More

Xealth lands investment from Cerner as COVID-19 accelerates digital health adoption, Werewolf Therapeutics appoints new CBO, and more portfolio news

AUGUST 2020

Evolent Health CEO to step down

Frank Williams, the CEO of Arlington health system consultancy Evolent …

Read More

Curavi Health merges with two other companies, Abridge makes it easier to understand conversations with your provider, and BlueSphere Bio welcomes a new scientific advisory board

JULY 2020

This app takes makes it easier to understand medical conversations with your healthcare provider

Abridge is …

Read More

Health Catalyst acquires Able Health, Curavi telemedicine assists in elder care, and Cavulus reports upward trend in MA market

MARCH 2020

Cavulus CEO Declares Medicare Advantage Upward Trend Gains Momentum During Latest Annual Election Period

Patrick Phillips, …

Read More